Schedule-Dependent T Cell Clonal Dynamics with combining 177Lu-PSMA-617 and Pembrolizumab in metastatic castration resistant prostate cancer. (SITC 2026) - Oct 2, 2026 - Abstract #645; Pres time: Nov 6, 2026; No abstract available
Metastases • Castration-Resistant Prostate Cancer • Genito-urinary Cancer • Oncology • Prostate Cancer • Solid Tumor
|
|
Anusha Muralidhar; Shloka Shukla; Matthew Clark; Averey Lea; Karen Law; Zenghua Fan; Elena Montauti; Aram Lyu; Serena Kwek; David Oh; Michael Evans; Rahul Aggarwal; Lawrence Fong
|